Has Lali Sekhon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $79,985 in general payments to Lali Sekhon, MD across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lali Sekhon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lali Sekhon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lali Sekhon, MD

Neurological Surgery · Reno, NVNPI 1639160500

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,913 of the $79,985 with a category attached, or 64.9%. 22 manufacturers reported payments, led by Medtronic at 58.0% of the total. 2025 is the largest year on record at $45,122, 8.0 times the $5,647 reported in 2019.

$79,985in general payments, 2019–2025

Across 203 payments — averaging $394.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$46K
Alphatec Spine, Inc$8K
Zimmer Biomet$6K
Synthes GmbH$5K
Kyocera Medical Technologies, Inc.$5K
Medacta USA, Inc.$4K
plus $6K from 16 others

What the payments were for

Consulting fees$51,91365%
Speaking & faculty fees$3,7505%
Travel & lodging$16,87521%
Food & beverage$7,3109%
Education$1370%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	89	$46,377
Alphatec Spine, Inc	17	$7,793
Zimmer Biomet	21	$5,760
Synthes GmbH	4	$5,283
Kyocera Medical Technologies, Inc.	2	$4,999
Medacta USA, Inc.	14	$3,828
VB Spine LLC	14	$2,380
Globus Medical	3	$1,465
Boston Scientific	9	$654
Implanet America, Inc.	2	$256
Medical Device Business Services, Inc.	2	$251
Nevro Corp.	5	$203
Stryker	8	$161
Goode Surgical Inc	2	$142
Abbott	2	$110
Highridge Medical LLC	1	$86
Camber Spine Technologies LLC	1	$75
Pfizer	3	$59
AbbVie	1	$29
Solventum Corporation	1	$25
Ossdsign USA Incorporated	1	$25
Kerecis Limited	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CATALYFT PL EXPANDABLE INTERBODY SYSTEM$15,242
Battalion TLIF - PC$4,000
SafeOp$4,000
MYSPINE$3,503
Knees-MyMobility$3,125
Other - Miscellaneous$2,441
CAPRI CORPECTOMY CAGE SYSTEM$1,995
STEALTHSTATION S8 PLATFORM$1,688
Excelsius - GPS$1,425
STEALTH AUTOGUIDE SYSTEM$973
Mobi-C$736
MAZOR X SYSTEM$621
Connected Health Product Portfolio$500
CD HORIZON SPINAL SYSTEM$384
TriCor$353
Timberline$310
ROSA Spine$297
STRATAFIX$251
UNID_PASS$139
CASCADIA INTERBODY SYSTEM$139

How this compares

$79,985 in reported general payments places this provider in the 80th percentile of 45 neurological surgery providers in Nevada.

See all neurological surgery providers in Nevada →

Medicare billing

Part B allowed, 2024

$368,724

Medicare patients

408

Services billed

1,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	311	$5,957
Gabapentin	212	$3,839
Baclofen	213	$3,227
Meloxicam	261	$2,025
Celecoxib	36	$1,438
Tizanidine Hcl	32	$346
Duloxetine Hcl	23	$293
Methylprednisolone	12	$51
Cyclobenzaprine Hcl	16	$32

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Reno

Edward PerryReno$196K
Michael SongReno$154K
James LynchReno$112K
Christopher DemersReno$71K
Jay MorganReno$43K
Angelique Sao Mai TayReno$39K
Rima RindlerReno$31K
Shane AbdunnurReno$24K
Marshall TolbertReno$8K
Michael MooreReno$2K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →